Eyüpoğlu ND, Çınar OE, Aksu S, et al. Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate. Acta Medica. 2022;53(3):277-283. https://doi.org/10.32552/2022.ActaMedica.745